CINECA IRIS Institutional Research Information System

GOITRE, Luca

GOITRE, Luca  

SCIENZE CLINICHE E BIOLOGICHE  

Mostra records
Risultati 1 - 20 di 61 (tempo di esecuzione: 0.039 secondi).
Titolo Data di pubblicazione Autore(i) File
Altered redox homeostasis and signaling in Cerebral Cavernous Malformation disease: towards a complex but unifying pathogenic mechanism and therapeutic implications 2018 Trapani, Eliana; Antognelli, Cinzia; Goitre, Luca; Perrelli, Andrea; Sarri, Sara; Barrera, Giuseppina; Talesa, Vincenzo; Trabalzini, Lorenza; Retta, Saverio Francesco
Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies 2016 Marchi, Saverio; Trapani, Eliana; Corricelli, Mariangela; Goitre, Luca; Pinton, Paolo; Retta, Saverio Francesco
Biological activities, health benefits, and therapeutic properties of avenanthramides: From skin protection to prevention and treatment of cerebrovascular diseases 2018 Perrelli, Andrea; Goitre, Luca; Salzano, Anna Maria; Moglia, Andrea; Scaloni, Andrea; Retta, Saverio Francesco
CCM Italia: pazienti, clinici e ricercatori “in rete” per migliorare conoscenza, management clinico e ricerca sulle Malformazioni Cavernose Cerebrali 2012 Saverio Francesco Retta; Cristina Spadaro; Luca Goitre; Alessandro Morina; Eliana Trapani; Rosalia Canzoneri; Valentina Cutano; Fabio Zanchetta; Maria Virdò
Cerebral Cavernous Malformations: from disease mechanisms to novel therapeutic approaches 2014 Goitre L.; Moglia A.; Trapani E.; Marchi S.; Pinton P.; Delle Monache S.; Cianfruglia L.; Armeni T.; Principato G.; Antognelli C.; Talesa V.; Tognon M.; Fontanella M.; Baldini E.; Trabalzini L.; Li D.Y.; Retta S.F.
Cerebral Cavernous Malformations: the CCM Italia research network offers new therapeutic perspectives 2013 Goitre L.; Cutano V.; Trapani E.; Morina A.; Canzoneri R.; Pergolizzi B.; Gianoglio S.; Moglia A.; Cianfruglia L.; Armeni T.; Delle Monache S.; Tognon M.; Fontanella M.; Baldini E.; Trabalzini L.; Retta S.F.
Characterization of the cellular functions of KRIT1, the disease gene responsible for type 1 Cerebral Cavernous Malformations (CCM1) 2007 AVOLIO M; FRANCALANCI F; DEGANI S; BALZAC F; GOITRE L; DE LUCA E; MARINO M; RECUPERO D; ORSO F; TAVERNA D; RETTA S
Combined Pulldown and Time-Lapse Microscopy Studies for Determining the Role of Rap1 in the Crosstalk Between Integrins and Cadherins 2014 Goitre, Luca; Retta, Saverio Francesco
Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1 2016 Choquet, Hélène; Trapani, Eliana; Goitre, Luca; Trabalzini, Lorenza; Akers, Amy; Fontanella, Marco; Hart, Blaine L.; Morrison, Leslie A.; Pawlikowska, Ludmila; Kim, Helen; Retta, Saverio Francesco
Defective autophagy is a key feature of cerebral cavernous malformations 2015 Marchi, Saverio; Corricelli, Mariangela; Trapani, Eliana; Bravi, Luca; Pittaro, Alessandra; Delle Monache, Simona; Ferroni, Letizia; Patergnani, Simone; Missiroli, Sonia; Goitre, Luca; Trabalzini, Lorenza; Rimessi, Alessandro; Giorgi, Carlotta; Zavan, Barbara; Cassoni, Paola; Dejana, Elisabetta; Retta, Saverio Francesco; Pinton, Paolo
Evaluation of the bioactive properties of avenanthramide analogs produced in recombinant yeast 2015 Moglia, Andrea; Goitre, Luca; Gianoglio, Silvia; Baldini, Eva; Trapani, Eliana; Genre, Andrea; Scattina, Antonella; Dondo, Giancarlo; Trabalzini, Lorenza; Beekwilder, Jules; Retta, Saverio Francesco
Fluorescence Microscopy Study of Rap1 Subcellular Localization 2014 Goitre, Luca; Valentina, Cutano; Retta, Saverio Francesco
Genetic and cellular basis of Cerebral Cavernous Malformations: implications for clinical management 2013 Bacigaluppi S; Retta SF; Pileggi S; Fontanella M; Goitre L; Tassi L; La Camera A; Citterio A; Patrosso MC; Tredici G; Penco S.
High yield production of avenanthramide analogous endowed with antioxidant properties 2014 Moglia A; Goitre L; Gianoglio S; Baldini E; Genre A; Trabalzini L; Beekwilder J; Retta S.F.
Identification of a novel KRIT1 interactor involved in the control of actin cytoskeleton dynamics and cell resistance to oxidative stress 2012 Guazzi P.; Goitre L.; Ferro E.; Cutano V.; Martino C.; Trabalzini L.; Retta S.F.
Identification of a novel KRIT1 interactor involved in the control of actin cytoskeleton dynamics and cell resistance to oxidative stress 2011 Trabalzini L.; Guazzi P.; Goitre L.; Cutano V.; Ferro E.; Martino C.; Retta S.F.
Identification of a novel KRIT1 interactor involved in the control of actin cytoskeleton dynamics. 2010 Guazzi P.; Ferro E.; Goitre L.; Martino C.; Cutano V.; Bettini C.; Retta S.F.; Trabalzini L
Identification of risk factors and biomarkers of diagnostic and prognostic value associated with clinical progression and severity of cerebral cavernous malformations 2018 Fornelli, Claudia; Trapani, Eliana; Mastrocola, Raffaella; Perrelli, Andrea; Benedetti, Valerio; Zotta, Alessia; Costantino, Giulia; Geddo, Federica; Boda, Enrica; Biasi, Fiorella; Goitre, Luca; Retta, Saverio Francesco
Identification of the Kelch family protein Nd1-L as a novel molecular interactor of KRIT1 2012 Guazzi P; Goitre L; Ferro E; Cutano V; Martino C; Trabalzini L; Retta SF
KRIT1 and Reactive Oxigen Species: a novel molecular pathway involved in Cerebral Cavernous Malformations. 2012 Goitre L.; Villoria-Recio M.; Cutano V.; Canzoneri R.; Trapani E.; Morina A.; Retta S.F.